BTS
Dead / Abandoned — Abandoned — no statement of use filed (as of 12 Aug 2024)
What this means for you
This application is over — abandoned 12 Aug 2024. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 90010886
- Mark type
- Stylized text
- Filed
- 19 Jun 2020
- Published for opposition
- 27 Oct 2020
- Abandoned
- 12 Aug 2024
- Attorney of record
- DANIEL HOPEN
Goods and services
- Class 042 — Scientific and technological services: Research in the field of pharmaceuticals for treatment of autoimmune diseases; Research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines; Scientific study and research in the field(s) of medicine, namely, for the prevention and treatment of cancer, tumor, autoimmune diseases, diabetes, cardiovascular diseases, ophthalmic diseases, infectious diseases, and respiratory diseases
Owner
- BTS Biopharma Inc., Reno, NV, US
- BTS Biopharma Inc., Elkridge, MD, US
Prosecution history
- 12 Aug 2024 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 12 Aug 2024 — ABANDONMENT - NO USE STATEMENT FILED
- 14 Feb 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 13 Feb 2024 — SOU EXTENSION 3 GRANTED
- 09 Jan 2024 — SOU EXTENSION 3 FILED
- 05 Feb 2024 — RESPONSE TO ITU OFFICE ACTION ENTERED
- 05 Feb 2024 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 11 Jan 2024 — ITU OFFICE ACTION ISSUED FOR EXTENSION REQUEST
- 09 Jan 2024 — SOU TEAS EXTENSION RECEIVED
- 19 Jul 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 18 Jul 2023 — SOU EXTENSION 2 GRANTED
- 11 Jul 2023 — SOU EXTENSION 2 FILED
- 18 Jul 2023 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 11 Jul 2023 — SOU TEAS EXTENSION RECEIVED
- 12 Jan 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED